0001145549-22-042410.txt : 20220714 0001145549-22-042410.hdr.sgml : 20220714 20220714153336 ACCESSION NUMBER: 0001145549-22-042410 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220430 FILED AS OF DATE: 20220714 DATE AS OF CHANGE: 20220714 EFFECTIVENESS DATE: 20220714 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WASHINGTON MUTUAL INVESTORS FUND CENTRAL INDEX KEY: 0000104865 IRS NUMBER: 520793788 FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-00604 FILM NUMBER: 221082979 BUSINESS ADDRESS: STREET 1: 333 S HOPE ST - 55TH FL (MICG) CITY: LOS ANGELES STATE: CA ZIP: 90071 BUSINESS PHONE: 213-486-9200 MAIL ADDRESS: STREET 1: 6455 IRVINE CENTER DRIVE CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: WASHINGTON MUTUAL INVESTORS FUND INC DATE OF NAME CHANGE: 19920703 0000104865 S000009388 WASHINGTON MUTUAL INVESTORS FUND C000025719 Class A AWSHX C000025720 Class R-1 RWMAX C000025721 Class R-2 RWMBX C000025722 Class R-3 RWMCX C000025723 Class R-4 RWMEX C000025724 Class R-5 RWMFX C000025726 Class C WSHCX C000025727 Class F-1 WSHFX C000025728 Class 529-A CWMAX C000025730 Class 529-C CWMCX C000025731 Class 529-E CWMEX C000025732 Class 529-F-1 CWMFX C000068526 Class F-2 WMFFX C000077924 R-6 RWMGX C000148358 Class R-2E RWEBX C000164825 Class R-5E RWMHX C000179991 Class F-3 FWMIX C000189454 Class 529-T TMWMX C000189455 Class T TWMMX C000221714 Class 529-F-2 FWMMX C000221715 Class 529-F-3 FWWMX N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0000104865 XXXXXXXX true false false N-1A true WASHINGTON MUTUAL INVESTORS FUND 811-00604 0000104865 GMJOUC23TOBOTKRA5C67 6455 Irvine Center Drive Irvine 92618 US-CA US 9499755000 Capital Research and Management Company 6455 Irvine Center Drive Irvine 92618 9499755000 Fund accounting and transaction settlement records N N N-1A 1 Y Alan N. Berro N/A Y Charles E. "C.E." Andrews N/A N Donald L. Nickles N/A N Eric H. Stern N/A Y Gina F. Adams N/A N John Knox Singleton N/A N Margaret Spellings N/A N Mary Davis Holt N/A N Nariman Farvardin N/A N Jane M. Scofield N/A 333 South Hope Street 55th Floor Los Angeles 90071 XXXXXX N N N N N N American Funds Distributors, Inc. 8-17168 000006247 N/A Y N PricewaterhouseCoopers LLP 00238 5493002GVO7EO8RNNS37 N N N N N N N WASHINGTON MUTUAL INVESTORS FUND S000009388 GMJOUC23TOBOTKRA5C67 N 21 0 0 N/A N N Y N N JPMorgan Chase Bank, N.A. 7H6GLXDRUGQFU57RNE97 N N Revenue sharing split 1233586065.000000000000 4397967.000000000000 Rule 12d1-1 (17 CFR 270.12d1-1) Rule 17a-7 (17 CFR 270.17a-7) Rule 22d-1 (17 CFR 270.22d-1) Rule 32a-4 (17 CFR 270.32a-4) Rule 12d1-4 (17 CFR 270.12d1-4) N N N N Capital Research and Management Company 801-8055 000110885 M02M7XSKLMK96MWKNF95 N American Funds Service Company 84-00316 N/A Y N N Refinitiv US LLC 213800HQORQAP68CJJ04 N Six Financial Information AG 506700D369548LQDC335 CH N Bloomberg L.P. 549300B56MD0ZC402L06 N ICE Data Pricing & Reference Data, LLC 5493000NQ9LYLDBCTL34 N PricingDirect Inc. 549300WIC0TOJ7N7GD54 N Virtu ITG Solutions Network, LLC N/A N Markit North America, Inc. 549300HLPTRASHS0E726 N N JPMorgan Chase Bank, N.A. N/A N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N American Funds Service Company 84-00316 SEC File number Y N N Capital Research and Management Company M02M7XSKLMK96MWKNF95 Y N N American Funds Distributors, Inc. 8-17168 000006247 N/A 0.0 J.P. Morgan Securities LLC 8-35008-1 000000079 ZBUT11V806EZRVTWT807 963904.000000000000 Morgan Stanley & Co. LLC 8-15869-1 000008209 9R7GPTSO7KV3UQJZQ078 918930.000000000000 Goldman Sachs & Co. LLC 8-00129-1 000000361 FOR8UP27PHTHYVLBNG30 727510.000000000000 RBC Capital Markets LLC 8-45411-1 000031194 549300LCO2FLSSVFFR64 570701.000000000000 Bank of America, N.A. 8-69787-1 000283942 B4TYDEB6GKMZO031MB27 562540.000000000000 Jefferies & Company Inc. 8-15074-1 000002347 58PU97L1C0WSRCWADL48 561379.000000000000 UBS AG N/A N/A BFM8T61CT2L1QCEMIK50 CH 496305.000000000000 Cowen and Company, LLC 8-22522-1 000007616 549300WR155U7DVMIW58 446747.000000000000 Citigroup Global Markets Inc. 8-08177-1 000007059 MBNUM2BPBDO7JBLYG310 430182.000000000000 Oppenheimer & Co. 8-40770-1 000000249 254900VH02JQR2L8XD64 410131.000000000000 10474443.000000000000 Citigroup Global Markets Inc. 8-08177-1 000007059 MBNUM2BPBDO7JBLYG310 290617098.000000000000 Wells Fargo Securities, LLC 8-65876-1 000126292 VYVVCKR63DVZZN70PB21 192667487.000000000000 Bank of America, N.A. 8-69787-1 000283942 B4TYDEB6GKMZO031MB27 187074550.000000000000 Stifel, Nicolaus & Company, Inc. 8-01447-1 000000793 5WUVMA08EYG4KEUPW589 158339346.000000000000 828698481.000000000000 Y 159917167452.000000000000 Uncommitted 1500000000.000000000000 N N N N true INTERNAL CONTROL RPT 2 internalcontrolwmif.htm WMIF INTERNAL CONTROL REPORT - 04/30/2022 PDFtoHTML Conversion Output
 
 

Report of Independent Registered Public Accounting Firm

To the Board of Trustees and Shareholders of Washington Mutual Investors Fund

In planning and performing our audit of the financial statements of Washington Mutual Investors Fund (the "Fund") as of and for the year ended April 30, 2022, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund's internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we do not express an opinion on the effectiveness of the Fund's internal control over financial reporting.

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company's assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis.

Our consideration of the Fund's internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control over financial reporting that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Fund's internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be material weaknesses as defined above as of April 30, 2022.

This report is intended solely for the information and use of the Board of Trustees of Washington Mutual Investors Fund and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.

/s/ PricewaterhouseCoopers LLP

Los Angeles, California

June 9, 2022

PricewaterhouseCoopers LLP, 601 South Figueroa Street, Los Angeles, CA 90017 T: (213) 356-6000,

F: (813) 637 4444, www.pwc.com/us